Medtronic expects to get US antitrust approval for Covidien merger by the end of November
MLex Summary: Medtronic Vice President Geoff Martha said that the company expects to get US antitrust approval for its planned $42.9 billion acquisition of Covidien by the end of November, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article